https://www.fiercepharma.com/pharma/cdc-advisory-panel-examines-gsk-pfizer-rsv-data-will-vote-afternoon-recommended-use
0
0
GSK and Pfizer RSV shots under CDC scrutiny, with vote today - FiercePharma
6/21/23 at 8:15am
Organization
FiercePharma
Author
FiercePharma
12 words
0
Comments
You are the first to view
Create an account or login to join the discussion